Stallion Laboratories pvt. ltd
Naresh Kumar Gaur is a seasoned professional in the pharmaceutical manufacturing sector, currently serving as the Executive Vice President of Operations at Stallion Laboratories Pvt. Ltd since April 2025, after a promotion to Vice President on July 14, 2025. Prior to this, Naresh held senior positions at Amneal Pharmaceuticals as Senior Vice President of Manufacturing Operations, and at Ranbaxy as Plant Head in Mohali. Naresh's extensive experience includes roles at Torrent Pharmaceuticals Ltd where responsibilities encompassed manufacturing and packing for regulated markets and overseeing tech transfer and capacity expansion projects, along with managerial positions at Sun Pharmaceutical Industries, Cadilla Pharma, and Ipca Labs. Naresh Kumar Gaur earned a Master’s degree in Pharmaceutics and Drug Design from Doctor Harisingh Gour Vishwavidyalaya and completed secondary education at Carmel Convent Secondary School in Gwalior.
This person is not in any teams
This person is not in any offices
Stallion Laboratories pvt. ltd
Stallion Laboratories incorporated in 1988 as an integrated private sector Pharmaceutical Formulation Manufacturer, has acquired an unmatched record of managing niche product in formulations with a WHO GMP approved production facility and GLP qualified stringent quality control. The path of success lies in its belief of creativity and no negotiation with the quality of work. Stallion Laboratories has emerged as a reputed pharmaceuticals company with a unique mix of inorganic and organic growth fuelled through a strategy of focused brand management , total quality management, zero defect manufacturing and customized selling concepts managed by a team of highly proficient industry professionals. Stallion Laboratories has established a wide network of distribution in the Indian market as well as on the international Arena with strategic alliances in the major Pharma markets viz. South Latin America, Africa, South East Asia, CIS region & Francophone countries. Stallion Laboratories is armed with WHO GMP , GLP & ISO 9001-2015 Certifications. Stallion Laboratories is coming up with Unit II which is proposed to be UK-MHRA, EU GMP & PICS approved plant. With its approval, Stallion aims to enter regulated markets.